LEPR and metabolic syndrome: This has also been discussed during CNS inflammation, as inflammasome activation by ceramide leads to hyperphosphorylation of leptin receptor (Obr) and thus abrogating signaling pathway, as observed during obesity and metabolic syndrome (135, 138).